Globus Medical (GMED) Cash & Current Investments (2011 - 2026)

Globus Medical (GMED) has 16 years of Cash & Current Investments data on file, last reported at $629.9 million in Q1 2026.

• Quarterly Cash & Current Investments rose 36.55% year-over-year to $629.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $629.9 million (up 36.55% YoY) and the FY2025 annual result came in at $557.2 million, down 37.39% from the prior year.
• Cash & Current Investments climbed to $629.9 million in Q1 2026, from $557.2 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $890.1 million in Q4 2024 to a low of $229.4 million in Q2 2025.
• A 5-year average of $506.9 million and a median of $473.3 million in 2022 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments jumped 71.9% — and 2025, when it plunged 53.45%.
• Tracing GMED's Cash & Current Investments over 5 years: stood at $446.1 million in 2022, then rose by 16.08% to $517.8 million in 2023, then jumped by 71.9% to $890.1 million in 2024, then slumped by 37.39% to $557.2 million in 2025, then gained by 13.03% to $629.9 million in 2026.
• The last three Cash & Current Investments figures came in at $629.9 million (Q1 2026), $557.2 million (Q4 2025), and $390.5 million (Q3 2025), per Business Quant data.